Stifel Nicolaus Reaffirms Buy on Sunrise Senior Living

Stifel Nicolaus is out with its report today on Sunrise Senior Living SRZ, reaffirming Buy. In a note to clients, Stifel Nicolaus writes, "Although cautioning that senior housing may be a lagging indicator, management indicated occupancy trends for Sunrise have held up well and Sunrise increased rates right through the downturn. We reaffirm our Buy rating on SRZ shares with a $12 target price equal to our NAV per share estimate." At the time of posting, shares of SRZ were trading pre-market at $8.30, down 1.89% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care FacilitiesStifel NicolausSunrise Senior Living
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!